Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group.

Blood Adv · 2023 · PMC10539874 · PMID 36477770

Europe PMC DOI

hedged sentence

0.0535

closest p · 1.1× alpha

0.0535

boldest claim

The sentences

at the edge of significanceP = .0535so close (0.05 < p ≤ 0.1)

In the multivariable analysis for OS, IPI at relapse was at the edge of significance level (HR = 2.59; 95% CI, 0.99-6.8; for IPI 3 to 5, P = .0535).

also in 60 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.